NO20000198D0 - Pyrazinderivater, deres fremstilling samt medikamenter inneholdende forbindelsene - Google Patents
Pyrazinderivater, deres fremstilling samt medikamenter inneholdende forbindelseneInfo
- Publication number
- NO20000198D0 NO20000198D0 NO20000198A NO20000198A NO20000198D0 NO 20000198 D0 NO20000198 D0 NO 20000198D0 NO 20000198 A NO20000198 A NO 20000198A NO 20000198 A NO20000198 A NO 20000198A NO 20000198 D0 NO20000198 D0 NO 20000198D0
- Authority
- NO
- Norway
- Prior art keywords
- ch2oh
- alk
- choh
- equal
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9709058A FR2766187B1 (fr) | 1997-07-17 | 1997-07-17 | Derives de pyrazine, leur preparation et les medicaments les contenant |
| PCT/FR1998/001542 WO1999003844A1 (fr) | 1997-07-17 | 1998-07-15 | Derives de pyrazine, leur preparation et les medicaments les contenant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20000198L NO20000198L (no) | 2000-01-14 |
| NO20000198D0 true NO20000198D0 (no) | 2000-01-14 |
Family
ID=9509300
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20000198A NO20000198D0 (no) | 1997-07-17 | 2000-01-14 | Pyrazinderivater, deres fremstilling samt medikamenter inneholdende forbindelsene |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6399613B1 (no) |
| EP (1) | EP1001944B1 (no) |
| JP (1) | JP4443036B2 (no) |
| KR (1) | KR20010021901A (no) |
| CN (1) | CN1264371A (no) |
| AT (1) | ATE251144T1 (no) |
| AU (1) | AU747127B2 (no) |
| BR (1) | BR9810880A (no) |
| CA (1) | CA2296727C (no) |
| DE (1) | DE69818679T2 (no) |
| DK (1) | DK1001944T3 (no) |
| ES (1) | ES2205536T3 (no) |
| FR (1) | FR2766187B1 (no) |
| HU (1) | HUP0004602A3 (no) |
| IL (1) | IL134040A0 (no) |
| MX (1) | MXPA00000280A (no) |
| NO (1) | NO20000198D0 (no) |
| NZ (1) | NZ501906A (no) |
| PL (1) | PL338148A1 (no) |
| PT (1) | PT1001944E (no) |
| RU (1) | RU2194703C2 (no) |
| SK (1) | SK482000A3 (no) |
| WO (1) | WO1999003844A1 (no) |
| ZA (1) | ZA986337B (no) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9905771D0 (en) * | 1999-03-12 | 1999-05-05 | Isis Innovation | Compounds |
| US7598278B2 (en) * | 2002-04-11 | 2009-10-06 | L'oreal | Administration of pyridinedicarboxylic acid compounds for stimulating or inducing the growth of human keratinous fibers and/or arresting their loss |
| EP2007768A2 (en) * | 2006-04-20 | 2008-12-31 | Teva Pharmaceutical Industries Ltd | Methods for preparing eszopiclone crystalline form a, substantially pure eszopiclone and optically enriched eszopiclone |
| EP1904499A1 (en) * | 2006-06-26 | 2008-04-02 | Teva Pharmaceutical Industries Ltd | Process for the preparation of zopiclone |
| WO2008094690A2 (en) * | 2007-01-31 | 2008-08-07 | Teva Pharmaceutical Industries Ltd. | Methods for preparing eszopiclone |
| CN101891679B (zh) * | 2009-05-19 | 2014-04-16 | 上海华明高技术（集团）有限公司 | 吡啶二甲酸与二氨基吡啶质子转移化合物的制备方法 |
| FR3030248B1 (fr) | 2014-12-22 | 2018-03-23 | L'oreal | Association derive d'acide pyridine-dicarboxylique/agent anti-oxydant particulier |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4220650A (en) * | 1978-10-18 | 1980-09-02 | Pfizer Inc. | Organic diamine therapeutic compositions and methods |
| DE3703959A1 (de) * | 1987-02-10 | 1988-08-18 | Hoechst Ag | Pyridin-2,4- und 2,5-dicarbonsaeureamide, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen |
| JPH01117863A (ja) * | 1987-10-30 | 1989-05-10 | Toyobo Co Ltd | 新規なアミド化合物 |
| DE4020570A1 (de) * | 1990-06-28 | 1992-01-02 | Hoechst Ag | 2,4- und 2,5-substituierte pyridin-n-oxide, verfahren zu deren herstellung sowie deren verwendung |
-
1997
- 1997-07-17 FR FR9709058A patent/FR2766187B1/fr not_active Expired - Fee Related
-
1998
- 1998-07-15 WO PCT/FR1998/001542 patent/WO1999003844A1/fr not_active Application Discontinuation
- 1998-07-15 AT AT98939676T patent/ATE251144T1/de not_active IP Right Cessation
- 1998-07-15 KR KR1020007000465A patent/KR20010021901A/ko not_active Application Discontinuation
- 1998-07-15 DK DK98939676T patent/DK1001944T3/da active
- 1998-07-15 PL PL98338148A patent/PL338148A1/xx unknown
- 1998-07-15 CN CN98807199A patent/CN1264371A/zh active Pending
- 1998-07-15 PT PT98939676T patent/PT1001944E/pt unknown
- 1998-07-15 IL IL13404098A patent/IL134040A0/xx unknown
- 1998-07-15 NZ NZ501906A patent/NZ501906A/en unknown
- 1998-07-15 EP EP98939676A patent/EP1001944B1/fr not_active Expired - Lifetime
- 1998-07-15 ES ES98939676T patent/ES2205536T3/es not_active Expired - Lifetime
- 1998-07-15 AU AU88102/98A patent/AU747127B2/en not_active Ceased
- 1998-07-15 HU HU0004602A patent/HUP0004602A3/hu unknown
- 1998-07-15 SK SK48-2000A patent/SK482000A3/sk unknown
- 1998-07-15 RU RU2000103449/04A patent/RU2194703C2/ru not_active IP Right Cessation
- 1998-07-15 CA CA002296727A patent/CA2296727C/fr not_active Expired - Fee Related
- 1998-07-15 JP JP2000503069A patent/JP4443036B2/ja not_active Expired - Fee Related
- 1998-07-15 BR BR9810880-8A patent/BR9810880A/pt not_active IP Right Cessation
- 1998-07-15 DE DE69818679T patent/DE69818679T2/de not_active Expired - Lifetime
- 1998-07-15 MX MXPA00000280A patent/MXPA00000280A/es unknown
- 1998-07-16 ZA ZA986337A patent/ZA986337B/xx unknown
-
2000
- 2000-01-14 NO NO20000198A patent/NO20000198D0/no not_active Application Discontinuation
- 2000-01-14 US US09/483,984 patent/US6399613B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0004602A2 (hu) | 2001-11-28 |
| DE69818679D1 (de) | 2003-11-06 |
| ZA986337B (en) | 1999-01-27 |
| CA2296727A1 (fr) | 1999-01-28 |
| MXPA00000280A (es) | 2002-04-17 |
| HUP0004602A3 (en) | 2001-12-28 |
| NO20000198L (no) | 2000-01-14 |
| KR20010021901A (ko) | 2001-03-15 |
| JP4443036B2 (ja) | 2010-03-31 |
| PL338148A1 (en) | 2000-09-25 |
| DK1001944T3 (da) | 2004-02-09 |
| WO1999003844A1 (fr) | 1999-01-28 |
| FR2766187A1 (fr) | 1999-01-22 |
| CA2296727C (fr) | 2009-06-09 |
| NZ501906A (en) | 2002-04-26 |
| JP2001510188A (ja) | 2001-07-31 |
| DE69818679T2 (de) | 2004-07-29 |
| CN1264371A (zh) | 2000-08-23 |
| AU747127B2 (en) | 2002-05-09 |
| SK482000A3 (en) | 2000-06-12 |
| ES2205536T3 (es) | 2004-05-01 |
| US6399613B1 (en) | 2002-06-04 |
| ATE251144T1 (de) | 2003-10-15 |
| EP1001944B1 (fr) | 2003-10-01 |
| FR2766187B1 (fr) | 2000-06-02 |
| PT1001944E (pt) | 2004-02-27 |
| IL134040A0 (en) | 2001-04-30 |
| BR9810880A (pt) | 2002-05-21 |
| EP1001944A1 (fr) | 2000-05-24 |
| RU2194703C2 (ru) | 2002-12-20 |
| AU8810298A (en) | 1999-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3029603T3 (en) | Cytotoxic stilbene derivatives and pharmaceutical composition containing them. | |
| FI965020A (fi) | Uusia yhdisteitä, menetelmiä niiden valmistamiseksi ja kasvaintenvastaisia aineita | |
| HK1022639A1 (en) | New use for 1,3-propanediol derivatives. | |
| FI840635A (fi) | Nya karbacykliner, foerfarande foer framstaellning av dem och deras anvaendning som laekemedel. | |
| IL123884A0 (en) | Active oxygen scavengers containing pterin derivatives | |
| DE68917341T2 (de) | Benzophenon-Derivate. | |
| SE7706392L (sv) | N-fosfonometylenmonoaminoalkanmono- och -polyfosfonsyror respektive n-fosfonometylendiaminoalkanpolyfosfonsyror samt sett for deras framstellning | |
| NO20000198L (no) | Pyrazinderivater, deres fremstilling samt medikamenter inneholdende forbindelsene | |
| ES8506979A1 (es) | Procedimiento para preparar nuevas sales de alquil (cadena larga) amonio de n-fosfonometilglicina | |
| ATE148128T1 (de) | Anthracyclinglycosid-derivate und verfahren zu ihrer herstellung | |
| ES8105741A1 (es) | Un procedimiento para preparar compuestos de tiofosfonato nosimetricos | |
| HUP9900088A2 (hu) | Pirimidinszármazékok, ezeket tartalmazó gyógyászati készítmények és eljárás előállításukra | |
| FI810632L (fi) | 5,6:8,9-tetrahydro-7h-dibenz (d f)azoninderivat deras framstaellning och foereningar innehaollande dem | |
| SE9701912D0 (sv) | Pharmaceutical composition and use thereof | |
| BG101942A (en) | Analogues of arginine having inhibiting activity on no-synthetase | |
| DK1001943T3 (da) | Polyhydroxyalkylpyrazinderivater, deres fremstilling samt medikamenter indeholdende disse forbindelser | |
| DE3864336D1 (en) | Aromatische thioaether. | |
| IL106080A (en) | Pharmaceutical compositions containing amidinoalkane-1, 1-bisphosphonic acids and some such novel compounds | |
| ATE96318T1 (de) | Acylaminoalkylpyridinamide als inhibitoren der tumormetastasierung. | |
| ES2061864T3 (es) | Sustancia antitumoral, procedimiento para su preparacion, y agente anticanceroso que la contiene. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |